Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Preferred Stock

v3.21.1
Note 10 - Preferred Stock
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Preferred Stock [Text Block]
10.
Preferred Stock
 
Series A Convertible Preferred Stock
 
On
December 16, 2020,
the Company filed a Certificate of Elimination with the Delaware Secretary of State with respect to the authorized shares of Series A convertible preferred stock. As of the date of the filing of the Certificate of Elimination,
no
shares of Series A convertible preferred stock were outstanding. Upon filing the Certificate of Elimination, the
547,345
authorized shares of Series A convertible preferred stock were returned to the status of authorized but unissued shares of preferred stock of the Company, without designation as to series or rights, preferences, privileges or limitations.
 
Series B Convertible Preferred Stock
 
As previously reported (see Note
6
– Note Payable), the CRG debt obligations converted into
31,300
shares of the newly authorized Series B convertible preferred stock and warrants to purchase up to
989,379
shares of common stock were also issued.
 
In connection with the CRG debt conversion, on
November 26, 2019,
the Company filed the Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock (the “Series B Certificate of Designation”) with the Secretary of State of the State of Delaware. The Series B Certificate of Designation provides for the issuance of the shares of Series B convertible preferred stock. The holders of Series B convertible preferred stock are entitled to receive compounding dividends at a rate of
12.5%
per annum payable quarterly at the Company's option through additional paid in-kind shares of Series B convertible preferred stock or in cash. During the
three
months ended
March 31, 2021,
the Company paid dividend in-kind of an additional
1,118
shares of Series B convertible preferred stock and a cash dividend of approximately
$1,000
for the remaining fractional shares. During the
three
months ended
March 31, 2020,
the Company paid dividend in-kind of an additional
989
shares of Series B convertible preferred stock and a cash dividend of approximately
$1,000
for the remaining fractional shares. The Company has paid approximately
$12,000
in cash and issued a total of
5,637
shares of Series B convertible preferred stock as preferred dividend to the holders of Series B convertible preferred stock through
March 31, 2021.
 
As of
March 31, 2021
and
December 31, 2020,
there were
36,937
and
35,819
shares of Series B convertible preferred stock outstanding and convertible into
2,414,183
and
2,341,111
shares of common stock, respectively. Each share of Series B convertible preferred stock is convertible at the holder's option into shares of common stock at a conversion ratio of
1
-for-
65.36
per share determined by dividing the Series B liquidation amount of
$1,000
per share by the Series B conversion price of
$15.30
per share. However, under the terms of the Series B Preferred Stock and Warrant Purchase Agreement, as amended, CRG will
not
convert the Series B preferred stock or exercise the CRG warrants until the Company's stockholders act to authorize additional number of shares of common stock sufficient to cover the conversion shares.
 
The shares of Series B convertible preferred stock have
no
voting rights and rank senior to all other classes and series of our equity in terms of repayment and certain other rights. 
 
The Series B convertible preferred stock also provides that for so long as any shares are outstanding, the consent of the holders of the Series B convertible preferred stockholders would be required to amend the Company's organizational documents, approve any merger, sale of assets, or other major corporate transaction, or incur additional indebtedness, among other items. 
 
Series C Convertible Preferred Stock
 
In connection with the closing of the public offering, on
January 19, 2021,
the Company filed the Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock (the “Series C Certificate of Designation”) with the Secretary of State of the State of Delaware. The Series C Certificate of Designation provides for the issuance of the shares of Series C convertible preferred stock. The shares of Series C convertible preferred stock rank on par with the shares of the common stock, in each case, as to dividend rights and distributions of assets upon liquidation, dissolution or winding up of the Company.
 
With certain exceptions, as described in the Series C Certificate of Designation, the shares of Series C convertible preferred stock have
no
voting rights.
 
Each share of Series C convertible preferred stock is convertible at any time at the holder's option into
one
share of common stock, which conversion ratio will be subject to adjustment for stock splits, stock dividends, distributions, subdivisions and combinations and other similar transactions as specified in the Series C Certificate of Designation.
 
A total of
2,450,880
shares of Series C convertible preferred stock were issued in the
January 2021
Offering. In
January 2021,
all Series C convertible preferred stock were converted into common stock and there are
no
remaining shares of Series C convertible preferred stock outstanding.